Search - tctmd.com

Displaying 321 - 340 of 681

Sort: Relevancy | Date

Presentation TCT 2014

Putting it All Together: Anticoagulants, Rhythm Control, and LAA Closure Which Therapy for Which Patient?

Presenter: Matthew J. Price, Shephal Doshi

September 15, 2014

Presentation TCT 2014

Shifting the Treatment Paradigm with LAA Closure: Efficacy, Complications, and Future Challenges

Presenter: Matthew J. Price

September 15, 2014

Presentation TCT 2014

The Triple Therapy Conundrum: Treatment of the PCI Patient with Atrial Fibrillation

Presenter: Matthew J. Price, C. Michael Gibson

September 15, 2014

Presentation TCT 2014

Bleeding and Stroke Risk Assessment in Atrial Fibrillation: Choosing between Warfarin, NOACS, Antiplatelets, or Nothing?

Presenter: Matthew J. Price, Michael D. Ezekowitz

September 15, 2014

News Industry News

New Study Evaluates “Triple Therapy” Regimens After Drug-Eluting Stenting in Patients Requiring Oral Anticoagulation

September 15, 2014

Presentation TCT 2014

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib

September 14, 2014

Presentation TCT 2014

Can LAA Closure Become the New Standard for Stroke Prevention?

Presenter: Hilary Nierenberg, Julie Logan, Saibal Kar

September 14, 2014

Presentation TCT 2014

Atrial Fibrillation: Stratifying Stroke Risk and Determining Anticoagulant Therapy

Presenter: Hilary Nierenberg, Julie Logan, Asma Hussaini

September 14, 2014

Presentation TCT 2014

The Electrophysiologists Approach to Managing Atrial Fibrillation

Presenter: Hilary Nierenberg, Julie Logan, Taya V. Glotzer

September 14, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

Presentation TCT 2014

Percutaneous Left Atrial Appendage Closure for Atrial Fibrillation: Where Are We Compared to New Drugs and Ablation

Presenter: Jose Luis Assad-Morell, Efrain Gaxiola, Matthew J. Price

September 13, 2014

News Conference News TCT 2014

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

Todd Neale

September 13, 2014

News Industry News

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

September 02, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Industry News

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

August 27, 2014

News Industry News

The ARROW® VPS G4™ Device, a Vascular Positioning System from Teleflex, Streamlines Placement of Central IV Catheters, Study Reports

August 25, 2014

News Industry News

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

August 25, 2014

News Daily News

Meta-analysis: Value of PFO Closure vs Medical Therapy Varies by Device

Caitlin E. Cox

August 20, 2014

News Industry News

The Lancet: Remote Monitoring Can Save ICD and CRT-D Patients’ Lives

August 15, 2014

News Industry News

Medtronic Receives FDA Approval for Attain Performa® Quadripolar Lead and Viva® Quad CRT-Ds in United States

August 07, 2014

Advertisement

Putting it All Together: Anticoagulants, Rhythm Control, and LAA Closure Which Therapy for Which Patient?

Shifting the Treatment Paradigm with LAA Closure: Efficacy, Complications, and Future Challenges

The Triple Therapy Conundrum: Treatment of the PCI Patient with Atrial Fibrillation

Bleeding and Stroke Risk Assessment in Atrial Fibrillation: Choosing between Warfarin, NOACS, Antiplatelets, or Nothing?

New Study Evaluates “Triple Therapy” Regimens After Drug-Eluting Stenting in Patients Requiring Oral Anticoagulation

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

Can LAA Closure Become the New Standard for Stroke Prevention?

Atrial Fibrillation: Stratifying Stroke Risk and Determining Anticoagulant Therapy

The Electrophysiologists Approach to Managing Atrial Fibrillation

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Percutaneous Left Atrial Appendage Closure for Atrial Fibrillation: Where Are We Compared to New Drugs and Ablation

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

The ARROW® VPS G4™ Device, a Vascular Positioning System from Teleflex, Streamlines Placement of Central IV Catheters, Study Reports

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

Meta-analysis: Value of PFO Closure vs Medical Therapy Varies by Device

The Lancet: Remote Monitoring Can Save ICD and CRT-D Patients’ Lives

Medtronic Receives FDA Approval for Attain Performa® Quadripolar Lead and Viva® Quad CRT-Ds in United States

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content